Rare
lephants
Screener
Toggle theme
Vistagen Therapeutics, Inc.
VTGN
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2024
$-1.52
$-2.63
FY2025
$-1.67
$-2.30
FY2026
$-1.83
$-1.09
Download CSV
